Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-64,500
Closed -$582K 4728
2025
Q4
$582K Buy
+64,500
New +$787K ﹤0.01% 2028
2022
Q2
Sell
-2,700
Closed -$209K 3725
2022
Q1
$209K Buy
+2,700
New +$169K ﹤0.01% 2468
2021
Q3
Sell
-6,520
Closed -$1.18M 3754
2021
Q2
$1.18M Buy
6,520
+4,010
+160% +$704K 0.01% 912
2021
Q1
$570K Sell
2,510
-4,500
-64% -$1.06M 0.01% 1669
2020
Q4
$579K Buy
+7,010
New +$511K 0.01% 947
2020
Q3
Sell
-2,000
Closed -$142K 2343
2020
Q2
$142K Buy
+2,000
New +$161K ﹤0.01% 1204
2019
Q4
Sell
-3,790
Closed -$937K 1639
2019
Q3
$937K Buy
+3,790
New +$1.38M 0.04% 386
2019
Q1
Sell
-3,240
Closed -$2.29M 782
2018
Q4
$2.29M Buy
+3,240
New +$3.55M 0.33% 56

Other funds holding TLRY

HRT Financial's TLRY Position: Q4 2025 in Review

HRT Financial sold out of Tilray (TLRY) in Q4 2025, closing a stake of 1,484,926 shares — an estimated $18.1M sold.

HRT Financial first reported a position in TLRY in Q1 2019 and held it in 14 quarters. The position peaked at $25.7M in Q3 2025. 220 funds tracked by Wall St. Rank hold TLRY as of Q4 2025.

  • HRT Financial reported no remaining Tilray position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 1,484,926 Tilray shares in Q4 2025, an estimated $18.1M.
  • HRT Financial first reported a position in Tilray in Q1 2019 and held it in 14 quarters.
  • HRT Financial's Tilray position peaked at $25.7M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Tilray as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.